CJ-17665
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | Antibiotics |
| Catalog number | BBF-02782 |
| CAS | |
| Molecular Weight | 451.56 |
| Molecular Formula | C26H33N3O4 |
Online Inquiry
Capabilities & Facilities
Fermentation Lab
4 R&D and scale-up labs
2 Preparative purification labs
Fermentation Plant
Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)
Product Description
CJ-17665 is produced by the strain of Aspergillus ochraceus. It inhibits growth of multi-drug resistant MRSA, Streptococcus pyogenes and Enterococcus faecalis with MIC of 12.5, 12.5 and 25 μg/mL, respectively.
- Specification
- Properties
- Price Product List
| IUPAC Name | (17S)-9,9,16,16-tetramethyl-14-oxido-8-oxa-23,25-diaza-14-azoniaheptacyclo[17.5.2.01,17.03,15.04,13.07,12.019,23]hexacosa-2,10,14-triene-24,26-dione |
| Canonical SMILES | CC1(C=CC2C(O1)CCC3C2[N+](=C4C3=CC56C(C4(C)C)CC7(CCCN7C5=O)C(=O)N6)[O-])C |
| InChI | InChI=1S/C26H33N3O4/c1-23(2)10-8-15-17(33-23)7-6-14-16-12-26-18(24(3,4)20(16)29(32)19(14)15)13-25(21(30)27-26)9-5-11-28(25)22(26)31/h8,10,12,14-15,17-19H,5-7,9,11,13H2,1-4H3,(H,27,30)/t14?,15?,17?,18-,19?,25?,26?/m0/s1 |
| InChI Key | ORSYLCGWTGPFIU-XQULAXQSSA-N |
| Appearance | White Powder |
| Antibiotic Activity Spectrum | Gram-positive bacteria |
| Boiling Point | 613.5±55.0°C at 760 mmHg |
| BBF-03488 | Streptozotocin | Inquiry |
| BBF-05843 | Bacitracin | Inquiry |
| BBF-02576 | Pneumocandin B0 | Inquiry |
| BBF-03211 | AT-265 | Inquiry |
| BBF-01210 | Emericid | Inquiry |
| BBF-03428 | Tubermycin B | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
